Metabolic disorders in patients with arterial hypertension with concomitant obesity
Journal Title: Український терапевтичний журнал - Year 2019, Vol 0, Issue 3
Abstract
Objective — further investigation of the pathogenetic triggers of arterial hypertension with concomitant obesity. Materials and methods. Examinations involved 111 patients with arterial hypertension (AH) with concomitant obesity (main group) and 18 patients with AH without obesity (comparison group). The age of the patients in the main group ranged from 41 to 67 years, on average (53.6 ± 7.35) years. The control group consisted of 24 practically healthy persons of representative age, which on average was (53.5 ± 7.7) years. The comparison group consisted of 18 patients with 1—2 degree arterial hypertension of the Ist and IInd stages, with an average age of (52.25 ± 6.41) years without obesity. Dopamine (DA) level was determined from the data from the daily excretion of dopamine with urine using a fluorometric method. The direct determination of angiotensin II (ATII) and aldosterone (ALD) was performed using an immune-enzymatic analysis. The concentration of lipids was determined using an enzymatic colorimetric method. Results and discussion. In patients with AH, a violation of the dopamine metabolism was detected in 88.8 % of patients with concomitant obesity and 69.2 % of patients without obesity, manifested by a decrease in the DA excretion with urine in 2.3 times (p < 0.001) and 2.0 times (p < 0.001), respectively, in comparison with the control group. The presence of concomitant obesity resulted in more profound disorder in the dopaminergic system, that manifested is the decreased DA levels in the daily urine by 14.6 % compared to patients with isolated AH (p < 0,001). Hyperactivation of renin-angiotensin-aldosterone system (RAAS) was more pronounced in patients with AH with concomitant obesity, accompanied by high levels of ATII and ALD: (47.45 ± 18.8) and (220.17 ± 108.8) versus (42.1 ± 5.2) pg/ml and (172.1 ± 18.9) pg/ml (p < 00.05; p < 0.001), (15.28 ± 2.9) and (119.78 ± 31.6) pg/ml (p < 0.001) in the group of patients with isolated AH and control respectively. The threshold DA range was 875—1060 mmol/l, with an excess of which the frequency of pathological levels of ALD and ATII significantly decreased (p < 0.05). Patients with AH, concomitant obesity and disturbances of dopamine metabolism has more pronounced atherogenic lipid profile, than patients with hypertension without obesity. Conclusions. As a result of the study, several violations of dopamine metabolism in patients with AH and associated obesity have been established. They manifested in the inhibition of the dopaminergic system, that confirmed the pathogenetic role of DA in the development of obesity against the background of hyperactivation of the renin-angiotensin-aldosterone system.
Authors and Affiliations
V. O. Sobol, V. G. Lizogub, O. G. Puzanova, Yu. O. Moshkovska
Keywords
Related Articles
- EP ID EP666941
- DOI 10.30978/UTJ2019-3-34
- Views 85
- Downloads 0
Matrix metalloproteinase-9 and connective tissue growth factor and their role in progression of hepato-myocardial fibrosis in patients with stable coronary heart disease combined with nonalcoholic fatty liver disease
Objective — to determine the regularities of the stable coronary heart disease (CHD) progression in condition of the formation of hepatomyocardial fibrosis by serum levels of matrix metalloproteinase-9 (MMP-9) and conne...
Peculiarities of indices of 24-hour ambulatory blood pressure monitoring in patients with essential hypertension, complicated with hemorrhagic stroke, after an early recovery period
Objective — to determine and evaluate indices of 24-hour ambulatory blood pressure monitoring (24-ABPM) in patients with essential hypertension (EH), complicated with hemorrhagic stroke (HS), after an early recovery peri...
Influence of combination of genetic haplotype of b1- and b2-adrenoreceptors on cardiac disease
Objective — to determine the prevalence and the effects of combined haplotypes of b1- and b2-adrenoreceptors genes on the course of heart failure. Materials and methods. 200 patients with heart failure were included to s...
The peculiarities of heart remodeling in patients after myocardial infarction with ST-segment elevation depending on the Lys198Asn polymorphism of endothelin 1 gene
Objective — to investigate clinical and genetic aspects of associations of Lys198Asn endothelin 1 (EDN 1) gene polymorphism with the development of remodeling after myocardial infarction with ST-segment elevation (STEMI)...
The relationship of macrophage migration inhibitory factor with clinical and anamnestic parameters in patients with ST-segment elevation myocardial infarction
Objective — to investigate the association between levels of the macrophage migration inhibitory factor (MIF) and the clinical and anamnestic parameters in patients with ST segment elevation myocardial infarction (STEMI)...